ES8307791A1 - "procedimiento para preparar derivados de nicotinoilbenzoguanamina". - Google Patents

"procedimiento para preparar derivados de nicotinoilbenzoguanamina".

Info

Publication number
ES8307791A1
ES8307791A1 ES512397A ES512397A ES8307791A1 ES 8307791 A1 ES8307791 A1 ES 8307791A1 ES 512397 A ES512397 A ES 512397A ES 512397 A ES512397 A ES 512397A ES 8307791 A1 ES8307791 A1 ES 8307791A1
Authority
ES
Spain
Prior art keywords
acid derivatives
nicotinic acid
nicotinoylbenzoguanamine
remedies
rheumatism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES512397A
Other languages
English (en)
Other versions
ES512397A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Shinyaku Co Ltd
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of ES512397A0 publication Critical patent/ES512397A0/es
Publication of ES8307791A1 publication Critical patent/ES8307791A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
    • C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
    • C07D251/18—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

PROCEDIMIENTO DE PREPARACION DE DERIVADOS DE NICOTILBENZOGUANAMINA. SE HACE REACCIONAR UN COMPUESTO DE FORMULA (II) EN DONDE X E Y PUEDEN SER IGUALES O DIFERENTES Y REPRESENTAN HIDROGENO O HALOGENO, EXCLUIDO EL CASO EN QUE TANTO X E Y SON HIDROGENO, Y Z REPRESENTA MONO-(ALCOHILO INFERIOR)-AMINO, DI-(ALCOHILO INFERIOR)AMINO, PIPERIDINO, PIRROLIDINO O MORFOLINO, CON UN DERIVADO DEL ACIDO NICOTINICO ACTIVADO, PARA DAR UN COMPUESTO DE FORMULA (I), EL CUAL SE TRANSFORMA EVENTUALMENTE EN UNA SAL DE ADICION DE ACIDO DEL MISMO. SON UTILES COMO REMEDIOS PARA EL REUMATISMO Y PARA LA NEFRITIS ALERGICA.
ES512397A 1981-06-05 1982-05-20 "procedimiento para preparar derivados de nicotinoilbenzoguanamina". Expired ES8307791A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56087124A JPS57203083A (en) 1981-06-05 1981-06-05 Nicotinic acid derivative

Publications (2)

Publication Number Publication Date
ES512397A0 ES512397A0 (es) 1983-08-01
ES8307791A1 true ES8307791A1 (es) 1983-08-01

Family

ID=13906203

Family Applications (1)

Application Number Title Priority Date Filing Date
ES512397A Expired ES8307791A1 (es) 1981-06-05 1982-05-20 "procedimiento para preparar derivados de nicotinoilbenzoguanamina".

Country Status (7)

Country Link
US (1) US4415570A (es)
EP (1) EP0066799B1 (es)
JP (1) JPS57203083A (es)
KR (1) KR880000807B1 (es)
CA (1) CA1185972A (es)
DE (1) DE3268253D1 (es)
ES (1) ES8307791A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59106473A (ja) * 1982-12-10 1984-06-20 Nippon Shinyaku Co Ltd トリアジン誘導体
MX9700928A (es) * 1994-08-08 1997-04-30 Nippon Shinyaku Co Ltd Derivado de triazian y medicina que lo contiene.
US5962453A (en) * 1995-08-08 1999-10-05 Nippon Shinyaku Co. Ltd. Triazine derivative and medicine
US7736636B2 (en) * 2003-02-12 2010-06-15 Shaker Mousa Method for treating occlusive vascular diseases & wound healing
WO2015155129A1 (en) * 2014-04-07 2015-10-15 Basf Se Diaminotriazine compound
CN105820133B (zh) * 2016-03-25 2018-06-05 浙江工业大学 多取代均三嗪类化合物及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1052988A (es) * 1962-07-03
GB1441904A (en) * 1974-02-18 1976-07-07 Nippon Shinyaku Co Ltd Benzoguanamine derivatives
JPS52118483A (en) * 1976-03-29 1977-10-04 Nippon Shinyaku Co Ltd Nicotinylaminotriazine derivatives
JPS5735587A (en) * 1980-06-04 1982-02-26 Nippon Shinyaku Co Ltd Benzoguanamine derivative
US4317822A (en) * 1980-07-02 1982-03-02 Merck & Co., Inc. 3-Amino-5-substituted-6-halo-N-(3,4-dihydro-6-substituted-1,3,5-triazin-2-yl)2-pyrazinecarboxamides

Also Published As

Publication number Publication date
DE3268253D1 (en) 1986-02-13
ES512397A0 (es) 1983-08-01
US4415570A (en) 1983-11-15
EP0066799B1 (en) 1986-01-02
EP0066799A2 (en) 1982-12-15
EP0066799A3 (en) 1983-01-26
JPS57203083A (en) 1982-12-13
CA1185972A (en) 1985-04-23
KR840000526A (ko) 1984-02-25
KR880000807B1 (ko) 1988-05-11

Similar Documents

Publication Publication Date Title
DK0623607T3 (da) Benzofuranyl- og -thiophenyl-alkancarboxylsyrederivater
PT87552A (pt) Process for the preparation of novel tetrazole intermediates toantihypertensive compounds
SE8804036L (sv) Ny anvaendning av 11,28-dioxa-4-azatricklo (22.3.1.04.9)-oktakos-18-en-derivat och farmaceutiska kompositioner innehaallande desamma
ES8801232A1 (es) Un procedimiento para la preparacion de acidos 3-hidroxifenoxialquilenheterociclilcarboxolicas.
ATE52766T1 (de) 2-oxyimino-3-oxo-buttersaeurederivate und deren herstellungsverfahren.
IT1229569B (it) Derivati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono.
ES2001703A6 (es) Procedimiento para la preparracion de derrrivados de acidos 2-(2-imidazolin -2-il)- piridin -3- carboxilicos.
MY115466A (en) Substituted cinnamic acid guanidides, a process for their preparation, their use as medicaments or diagnostic agents and medicaments comprising them.
TW272973B (es)
ATE40369T1 (de) Purinderivate.
SE8405588D0 (sv) New compounds
AU548628B2 (en) Novel guanidine derivatives
ES8306994A1 (es) Procedimiento para la obtencion de diamidas de acido hidroxi-maloico sustituidas.
DE2965701D1 (en) 1-imidazol-2-ylidene-3-thienyl-urea derivatives, processes therefor, and pharmaceutical compositions
GB1364294A (en) 2-styrylquinazoline compounds
DE59010865D1 (de) N-substituierte naphthalimide, ihre herstellung und verwendung
ES8801633A1 (es) Procedimiento para preparar nuevos derivados de 3-piridil-metilnaftilo
ES466794A1 (es) Un procedimiento para la preparacion de derivados de imida- zol.
PL297368A1 (en) Novel derivatives of 2h-benzo (b) pyrane substituted with aryl or n-heteroaryl at position 4, method of obtaining them and their applications as well as preparation containing these compounds
DE3363740D1 (en) 3-pyridyl-5-alkoxy-(or phenoxy- or aralkyloxy-)pyrazole derivatives, process for their preparation, and their therapeutical use
DE3880304D1 (de) 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung.
ES8802033A1 (es) Procedimiento para preparar compuestos de imidazolilo
DE3362523D1 (en) Optically active imidazolylpropanol compounds, and their production and use
EP0049538A3 (de) Verwendung von Thioharnstoffderivaten als Arzneimittel bei der Behandlung von Fettstoffwechselstörungen
ES8103760A1 (es) Procedimiento de preparacion de (20 s) - 3 - - ((aminoace- til)amino)-5 - - pregnan- 20 - ol

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519